Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Large-scale testing (Phase 3)Study completedNCT01515007
What this trial is testing

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

Who this might be right for
Non Cystic Fibrosis Bronchiectasis
Aradigm Corporation 278
Testing effectiveness (Phase 2)Study completedNCT04596319
What this trial is testing

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas AeruginosaPseudomonas+2 more
Armata Pharmaceuticals, Inc. 29
Post-approval studies (Phase 4)Ended earlyNCT02248922
What this trial is testing

Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa

Who this might be right for
Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis
Novartis Pharmaceuticals 17
Post-approval studies (Phase 4)Study completedNCT00411736
What this trial is testing

Scandinavian Cystic Fibrosis Azithromycin Study

Who this might be right for
Cystic Fibrosis
Rigshospitalet, Denmark 45
Large-scale testing (Phase 3)Study completedNCT01641822
What this trial is testing

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Who this might be right for
Cystic Fibrosis
Gilead Sciences 107
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Large-scale testing (Phase 3)WithdrawnNCT01315691
What this trial is testing

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated
Large-scale testing (Phase 3)Study completedNCT01315678
What this trial is testing

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Who this might be right for
Pseudomonas Aeruginosa Infection
Insmed Incorporated 302
Testing effectiveness (Phase 2)Looking for participantsNCT06016088
What this trial is testing

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Who this might be right for
Cystic Fibrosis LungRespiratory Infections, Recurrent, ChronicPseudomonas Aeruginosa
Respirion Pharmaceuticals Pty Ltd 72
Early research (Phase 1)Study completedNCT06238856
What this trial is testing

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 18
Large-scale testing (Phase 3)Study completedNCT02104245
What this trial is testing

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)

Who this might be right for
Non Cystic Fibrosis Bronchiectasis
Aradigm Corporation 304
Testing effectiveness (Phase 2)Study completedNCT00777296
What this trial is testing

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 66
Testing effectiveness (Phase 2)Study completedNCT00097773
What this trial is testing

Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis

Who this might be right for
Cystic FibrosisPulmonary Disease, Chronic Obstructive
Seattle Children's Hospital 304
Testing effectiveness (Phase 2)Study completedNCT05616221
What this trial is testing

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

Who this might be right for
Non-cystic Fibrosis BronchiectasisPseudomonas AeruginosaLung Infection
Armata Pharmaceuticals, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT06998043
What this trial is testing

Study With Phage for CF Subjects With Pseudomonas Lung Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis (CF)
BiomX Ltd 63
Testing effectiveness (Phase 2)Study completedNCT00558844
What this trial is testing

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 41
Large-scale testing (Phase 3)Study completedNCT01316276
What this trial is testing

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 206
Testing effectiveness (Phase 2)Study completedNCT03905642
What this trial is testing

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 49
Large-scale testing (Phase 3)Study completedNCT00885365
What this trial is testing

A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 324
Large-scale testing (Phase 3)Ended earlyNCT03460704
What this trial is testing

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

Who this might be right for
Non Cystic Fibrosis Bronchiectasis
Zambon SpA 287
Load More Results